Valentino LA - Search Results

1

Surgical excision of a giant pelvic pseudotumour in a patient with haemophilia A.

Valentino LA, Martinowitz U, Doolas A, Murali P. Valentino LA, et al. Haemophilia. 2006 Sep;12(5):541-4. doi: 10.1111/j.1365-2516.2006.01318.x. Haemophilia. 2006. PMID: 16919086

2

Pharmacokinetic properties of IB1001, an investigational recombinant factor IX, in patients with haemophilia B: repeat pharmacokinetic evaluation and sialylation analysis.

Martinowitz U, Shapiro A, Quon DV, Escobar M, Kempton C, Collins PW, Chowdary P, Makris M, Mannucci PM, Morfini M, Valentino LA, Gomperts E, Lee M. Martinowitz U, et al. Among authors: valentino la. Haemophilia. 2012 Nov;18(6):881-7. doi: 10.1111/j.1365-2516.2012.02897.x. Epub 2012 Jul 5. Haemophilia. 2012. PMID: 22764744 Clinical Trial.

3

Experience with a third generation recombinant factor VIII concentrate (Advate) for immune tolerance induction in patients with haemophilia A.

Valentino LA, Recht M, Dipaola J, Shapiro AD, Pipe SW, Ewing N, Urgo J, Bullock T, Simmons M, Deguzman C. Valentino LA, et al. Haemophilia. 2009 May;15(3):718-26. doi: 10.1111/j.1365-2516.2008.01960.x. Epub 2009 Feb 27. Haemophilia. 2009. PMID: 19298383 Free article.

4

Surgical experience with rFVIIa (NovoSeven) in congenital haemophilia A and B patients with inhibitors to factors VIII or IX.

Valentino LA, Cooper DL, Goldstein B. Valentino LA, et al. Haemophilia. 2011 Jul;17(4):579-89. doi: 10.1111/j.1365-2516.2010.02460.x. Epub 2011 Feb 7. Haemophilia. 2011. PMID: 21294815 Review.

5

Considerations in individualizing prophylaxis in patients with haemophilia A.

Valentino LA. Valentino LA. Haemophilia. 2014 Sep;20(5):607-15. doi: 10.1111/hae.12438. Epub 2014 Apr 8. Haemophilia. 2014. PMID: 24712891 Review.

6

Assessing the benefits of FEIBA prophylaxis in haemophilia patients with inhibitors.

Valentino LA. Valentino LA. Haemophilia. 2010 Mar;16(2):263-71. doi: 10.1111/j.1365-2516.2009.02126.x. Epub 2009 Dec 16. Haemophilia. 2010. PMID: 20028421

7

Controversies regarding the prophylactic management of adults with severe haemophilia A.

Valentino LA. Valentino LA. Haemophilia. 2009 Dec;15 Suppl 2:5-18, quiz 19-22. doi: 10.1111/j.1365-2516.2009.02159.x. Haemophilia. 2009. PMID: 20041959 No abstract available.

8

Healthcare resource utilization among haemophilia A patients in the United States.

Valentino LA, Pipe SW, Tarantino MD, Ye X, Xiong Y, Luo MP. Valentino LA, et al. Haemophilia. 2012 May;18(3):332-8. doi: 10.1111/j.1365-2516.2011.02677.x. Epub 2011 Nov 2. Haemophilia. 2012. PMID: 22044662

9

Patient- and caregiver-reported bleeding symptoms and reasons for starting and stopping treatment with recombinant factor VIIa: analysis of the Dosing Observational Study in Haemophilia (DOSE).

Valentino LA, Walsh CE, Reding MT, Young GA, Levendoglu-Tugal O, Cooper DL. Valentino LA, et al. Haemophilia. 2012 Jul;18(4):554-60. doi: 10.1111/j.1365-2516.2012.02762.x. Epub 2012 Feb 20. Haemophilia. 2012. PMID: 22348407

10

The benefits of prophylactic treatment with APCC in patients with haemophilia and high-titre inhibitors: a retrospective case series.

Valentino LA. Valentino LA. Haemophilia. 2009 May;15(3):733-42. doi: 10.1111/j.1365-2516.2009.01980.x. Epub 2009 Feb 23. Haemophilia. 2009. PMID: 19298380

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

148 results

Search Page

Filters